EORTC protocol 16902B

Phase II trial of Elsamitrucin (BMY 28090) in patients with advanced breast cancer
Trial StatusAll trial activities ended
DatesDate of activation: 01-May-91
Closed on : 01-Apr-92
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size25
Number of steps1
Drug
Study StaffPer Dombernowsky (Study Coordinator) - Herlev Hospital - University Copenhagen, Herlev
Type of cancerBreast
Participating GroupsEORTC Early Clinical Studies Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section